Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Providers
January 12, 2016 12:00 AM

Tools to choose effective cancer treatment are too many, too rigid: oncologists

Sabriya Rice
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Getty Images

    On a typical day, oncologist Dr. Linda Bosserman spends hours poring over lists meant to guide clinicians toward the optimal course of treatment. These "clinical pathways" are based on the cancer's stage and location in the body, and patient-specific factors, like comorbidities.

    Then, after she and the patient have chosen a plan, Bosserman says she spends hours explaining to payers how and why the choice was made.

    Because payers and for-profit companies create and distribute these pathways and because many are tailored to different agendas, the process is laden with inadequacies, conflicts of interest and “unsustainable” administrative burden, said the American Society of Clinical Oncology in a new policy statement, of which Bosserman was the senior author.

    “The administrative burden is at a breaking point,” said Bosserman, who works at City of Hope, a not-for-profit cancer research center in Southern California.

    While it is difficult to estimate how many clinical oncology pathways exist, they are likely well into the thousands. The pathways work on what might be described as an "if-then" format. For example, if the patient has breast cancer that has metastasized, then X has shown to have the best results; or if the lung cancer patient also has diabetes, then Y would be better.

    The pathways were first created more than a decade ago when personalized care began to trend. But some argue they've had the opposite effect.

    Cookie-cutter approaches can impede the ability to personalize care, said Dr. Robin Zon, chair of ASCO's Task Force on Clinical Pathways.

    In too many cases, clinical pathways undermine physicians' ability to optimally care for patients, ASCO President Dr. Julie Vose said in a news release.

    “The authorization and preauthorization work is taking away from our face to face time with patients,” Bosserman said. “Pathways are here to support doctors and patients, but they need to be comprehensive and they need to be practical.”

    The National Comprehensive Cancer Network's guidelines to treat more than 40 different types of cancers alone includes hundreds of pathways for each cancer. Each tool breaks down the specific courses to follow based on the tumor size, whether it has metastasized, or if the patient has other chronic conditions, like heart disease or diabetes.

    For each patient and for each type of disease, a provider may be faced with multiple pathways created by different interest groups. According to the ASCO task force, these may include payers, who incentivize certain pathways by offering increased reimbursement or shared savings. Benefit management organizations, or intermediaries between providers and payers, also create pathways that favor cancer drugs.

    At least six companies actively market oncology pathways, ASCO revealed in its research, without naming them. A report from the Advisory Board lists three; Innovent, P4 and Via Oncology.

    The Via Oncology pathway program was developed more than a decade ago and was used at the University of Pittsburgh Medical Center before it expanded commercially in 2009. The pathways are now used at 25 UPMC sites in Western Pennsylvania and by numerous provider groups throughout the country, including five academic medical centers.

    The system's chief medical officer, Dr. Peter Ellis, agrees with ASCO that it's time to regulate clinical pathways. Ellis said that if one were to print the full list of pathways created by Via Oncology's oncology committees, "It would be more than 12,000 pages."

    “The unfortunate truth is that people have bastardized what the name pathways means, using it to further other means,” he said. “They should not be about limiting care to patients, but rather making sure the care patients get is the best evidence-based care.”

    Ellis voiced other concerns with pathway development in a 2010 post in Oncology Times, called "All clinical pathways are not created equal."

    Concerns need to be addressed “as rapidly as possible,” ASCO said in its nine recommendations. It recommends better collaboration among payers and the oncology community to adopt flexible policies; consistent and transparent methodologies for pathway development; changes that allow pathways to be updated more rapidly, in real-time; and more focus on the full spectrum of care, from diagnosis to end of life.

    The report falls in line with other projects the oncology group has been pushing to help physicians and patients choose appropriate therapies amid the skyrocketing costs of cancer drugs. In June, ASCO released a tool for oncologists to compare various drug treatments for four common cancers based on survival, side effects and costs.

    They have also been finalizing CancerLinQ, a not-for-profit subsidiary that is bringing together more than a dozen oncology groups for a big data initiative. The participating practices share data from millions of electronic health records, with the goal of providing real-time feedback on cancer trends and patient outcomes.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    The Check Up: Bobby Sepucha, Interwell Health
    The Check Up: Bobby Sepucha, Interwell Health
    hospital mergers roundtable
    CEOs sound off on mergers, healthcare disruptors
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Modern Healthcare A.M. Newsletter: Sign up to receive a comprehensive weekday morning newsletter designed for busy healthcare executives who need the latest and most important healthcare news and analysis.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing